Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
121.22
-1.40 (-1.14%)
At close: Dec 5, 2025, 4:00 PM EST
121.59
+0.37 (0.31%)
After-hours: Dec 5, 2025, 7:58 PM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
According to 22 professional analysts, the 12-month price target for Gilead Sciences stock ranges from a low of $80 to a high of $150. The average analyst price target of $123.45 forecasts a 1.84% increase in the stock price over the next year.
Price Target: $123.45 (+1.84%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 6 | 7 |
| Buy | 13 | 12 | 12 | 12 | 10 | 10 |
| Hold | 9 | 8 | 7 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 25 | 24 | 24 | 23 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Initiates $145 → $140 | Strong Buy | Initiates | $145 → $140 | +15.49% | Nov 24, 2025 |
| Needham | Needham | Strong Buy Maintains $133 → $140 | Strong Buy | Maintains | $133 → $140 | +15.49% | Nov 13, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $140 | Buy | Initiates | $140 | +15.49% | Nov 13, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $127 → $145 | Strong Buy | Reiterates | $127 → $145 | +19.62% | Nov 3, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $140 → $145 | Buy | Maintains | $140 → $145 | +19.62% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
29.80B
from 28.75B
Increased by 3.63%
Revenue Next Year
30.68B
from 29.80B
Increased by 2.97%
EPS This Year
8.33
from 0.38
Increased by 2,090.97%
EPS Next Year
8.86
from 8.33
Increased by 6.48%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 31.2B | 32.8B | ||||
| Avg | 29.8B | 30.7B | ||||
| Low | 28.0B | 28.1B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.5% | 10.1% | ||||
| Avg | 3.6% | 3.0% | ||||
| Low | -2.5% | -5.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 8.85 | 9.98 | ||||
| Avg | 8.33 | 8.86 | ||||
| Low | 7.89 | 6.25 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 2,229.3% | 19.8% | ||||
| Avg | 2,091.0% | 6.5% | ||||
| Low | 1,976.1% | -24.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.